Jubilant Pharmova Ltd.
Snapshot View

View in App

Prices View details >>

282.05 +10.40 ▲3.8%

29 March 2023, 04:01:00 PM
Volume: 12,058

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jubilantpharmova.com
Market Cap 4,439.17 Cr.
Enterprise Value(EV) 6,812.25 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 6.05 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 46.60 Trailing Twelve Months Ending 2022-12
Industry PE 32.17 Trailing Twelve Months Ending 2022-12
Book Value / Share 336.20 Trailing Twelve Months Ending 2022-12
Price to Book Value 0.84 Calculated using Price: 282.05
Dividend Yield 1.79 Period Ending 2022-03
No. of Shares Subscribed 15.93 Cr. 159,281,139 Shares
FaceValue 1
Company Profile
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients, drug discovery solutions and India branded pharmaceuticals. Jubilant Pharma Limited, is engaged in manufacturing and supply of APIs, solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile injectables and non-sterile products through six USFDA approved manufacturing facilities in the US, Canada and India and a network of various radiopharmacies in the US.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+3.83%
1 Week
-5.68%
1 Month
-7.98%
3 Month
-25.02%
6 Month
-14.62%
1 Year
-29.43%
2 Year
-57.54%
5 Year
-66.41%
10 Year
+66.16%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 5.39 -1.58 14.27 17.95 16.87 12.97 13.02 10.88 8.41
Return on Capital Employed (%) 7.92 5.72 12.42 14.44 15.21 13.06 12.20 11.89 10.09
Return on Assets (%) 1.60 -0.46 4.46 6.52 6.91 5.55 5.74 5.34 4.55

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 2,627 2,454 2,966 3,436 4,087 4,809 5,604 4,741 5,319 5,476
Non Curr. Liab. 2,185 4,036 3,347 3,826 3,417 4,420 4,088 2,973 2,922 3,524
Curr. Liab. 3,894 2,129 2,464 1,684 2,005 2,090 2,619 1,049 1,592 1,491
Minority Int. 158 -38 -47 -52 0 0 -2 -4
Equity & Liab. 8,864 8,619 8,740 8,899 9,457 11,319 12,310 8,763 9,830 10,486
Non Curr. Assets 5,936 5,904 5,864 5,951 6,267 6,734 7,272 5,811 6,320 6,866
Curr. Assets 2,928 2,715 2,875 2,948 3,190 4,585 5,038 2,953 3,509 3,620
Misc. Exp. not W/O
Total Assets 8,864 8,619 8,740 8,899 9,457 11,319 12,310 8,763 9,830 10,486

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 5,803 5,826 5,749 5,861 7,518 9,111 5,976 6,099 6,130 6,131
Other Income 19 42 13 25 40 36 37 18 11 31
Total Income 5,822 5,869 5,763 5,886 7,558 9,147 6,013 6,116 6,141 6,162
Total Expenditure -4,782 -5,125 -4,502 -4,516 -5,999 -7,372 -4,428 -4,702 -4,974 -5,327
PBIDT 1,040 744 1,260 1,370 1,558 1,775 1,585 1,414 1,168 835
Interest -337 -368 -371 -341 -284 -220 -200 -184 -145 -172
Depreciation -281 -288 -347 -291 -415 -371 -340 -349 -382 -383
Taxation -70 -80 -155 -163 -225 -327 -335 -297 -217 -125
Exceptional Items -214 -48 -280 -33 -21 -57
PAT 138 -40 387 575 634 577 678 563 423 98
Minority Interest -29 -18 5 1 8 -3 0 1 2
Share Associate 11 -10 -3
Other Related Items
Consolidated Net Profit 109 -58 392 576 643 574 898 836 414 96
Adjusted EPS 7 -4 25 37 41 36 56 53 26 6

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 970 772 783 1,099 1,268 1,303 1,122 1,543 1,784 838
Cash Fr. Inv. -500 -174 -343 -313 -450 -618 -1,012 -327 -739 -380
Cash Fr. Finan. -450 -414 -503 -843 -686 -901 657 -1,050 -1,709 -33
Net Change 20 183 -63 -56 132 -216 767 166 -664 425
Cash & Cash Eqvt 280 473 392 339 456 244 1,005 1,231 502 984

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 50.68 50.68 50.68 50.68 50.68 50.68 50.68 50.68 50.68
Public 49.32 49.32 49.32 49.33 49.32 49.32 49.32 49.32 49.32
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 24 Mar 2023
Closure of Trading Window
Closure of trading window
Fri, 17 Mar 2023
Additional Loan Facility By Government Of Canada For The Expansion Of CMO Montreal Facility
We enclose a communication pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.We request you to take the same on record.
Tue, 14 Mar 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Dear Sirs In continuation of our letter dated March 13 2023 we enclose herewith copies of the advertisements published on March 14 2023 in Mint (All editions-English language) and Hindustan (Hindi language) with respect to the completion of dispatch of notices of Postal Ballot.This is for your information and record.

Technical Scans View Details >>

Wed, 29 Mar 2023
Opening at High Opening at High
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 76,011.65 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,756.97 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.86 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.30 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.45 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 6.01 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.19 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.25 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Jubilant Pharmova Ltd.

What is Jubilant Pharmova share price?
Can I buy Jubilant Pharmova shares now?
What is the Dividend Yield of Jubilant Pharmova?
What is the Market Cap of Jubilant Pharmova?
What are the key metrics to analyse Jubilant Pharmova?
What is the 52 Week High and Low of Jubilant Pharmova?
What is the trend of Jubilant Pharmova share price?